Skip to main content

Advertisement

Log in

Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Carrazana E, Mikoshiba I (2003) Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manag 25(5 Suppl):S31–S35

    Article  CAS  Google Scholar 

  2. Chantaphakul H, Sanon T, Klaewsongkram J (2015) Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Ther Med 10:519–524

    PubMed  PubMed Central  Google Scholar 

  3. Cruccua G, Gronsethb G, Alksnec J, Argoffd C, Brainine M, Burchiel K, et al. (2008) AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 15:1013–1028

    Article  Google Scholar 

  4. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:1113–1123

    Article  CAS  PubMed  Google Scholar 

  5. Bendtsen L, Birk S, Kasch H, Aegidius K, Sørensen PS, Thomsen LL, et al. (2012) Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. J Headache Pain 13(Suppl 1):S1–S29

    Article  PubMed  Google Scholar 

  6. Kutluay E, McCague K, D'Souza J, Beydoun A (2003) Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 4:175–180.

  7. Hellewell JS (2002) Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability. J Affect Disord 72(Suppl 1):S23–S34

    Article  CAS  PubMed  Google Scholar 

  8. Di Stefano G, La Cesa S, Truini A, Cruccu G (2014) Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain 15:34

    Article  PubMed  PubMed Central  Google Scholar 

  9. Besi E, Boniface DR, Cregg R, Zakrzewska JM (2015) Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP). J Headache Pain 16:563

    Article  CAS  PubMed  Google Scholar 

  10. Saconato H, Prado GF, Puga ME, Atallah AN (2009) Oxcarbazepine for refractory epilepsy: systematic review of the literature. Sao Paulo Med J 127:150–159

    Article  PubMed  Google Scholar 

  11. Dirección General de Medicamentos, Insumos y Drogas (2015) Observatorio de productos farmacéuticos. Lima, DIGEMID.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reneé Pereyra-Elías.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poletti-Jabbour, J., Wiegering-Rospigliosi, A., Pereyra-Elías, R. et al. Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap. Eur J Clin Pharmacol 72, 1031–1032 (2016). https://doi.org/10.1007/s00228-016-2066-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-016-2066-5

Keywords

Navigation